This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

William Winston, Ph.D.
Vice President, Research at Werewolf Therapeutics

Agenda Sessions

Engineering Novel Conditionally Activated Immune Therapeutics to Fight Cancer
On Demand
View Session
Inducible Activation of Antibodies to Enhance Therapeutic Index
3:30pm
View Session

Speakers at this event

Karl Dane Wittrup, Ph.D.

C.P. Dubbs Professor

Massachusetts Institute of Technology

William Winston, Ph.D.Vice President, Research at Werewolf Therapeutics

Agenda Sessions

Speakers at this event

See William Speak

William Winston, Ph.D.
Vice President, Research at Werewolf Therapeutics